Simwela, N. V., Guiguemde, W. A., Straimer, J., Regnault, C., Yokokawa, F., Taft, B., Diagana, T. T., Barrett, M. P. and Waters, A. P. (2023) A conserved metabolic signature associated with response to fast-acting anti-malarial agents. Microbiology Spectrum, (doi: 10.1128/spectrum.03976-22) (PMID:37800971) (Early Online Publication)

Russell, A. J. C. et al. (2023) Regulators of male and female sexual development are critical for the transmission of a malaria parasite. Cell Host and Microbe, 31(2), 305-319.e10. (doi: 10.1016/j.chom.2022.12.011) (PMID:36634679)

Simwela, N. V. and Waters, A. P. (2022) Current status of experimental models for the study of malaria. Parasitology, 149(6), pp. 729-750. (doi: 10.1017/S0031182021002134) (PMID:35357277)

Simwela, N., Hughes, K. R., Rennie, M. T., Barrett, M. P. and Waters, A. P. (2021) Mammalian deubiquitinating enzyme inhibitors display. ACS Infectious Diseases, 7(2), pp. 333-346. (doi: 10.1021/acsinfecdis.0c00580) (PMID:33400499)

Simwela, N., Stokes, B. H., Aghabi, D., Bogyo, M., Fidock, D. A. and Waters, A. (2020) Plasmodium berghei K13 mutations mediate in vivo artemisinin resistance that is reversed by proteasome inhibition. mBio, 11, e02312-20. (doi: 10.1128/mBio.02312-20) (PMID:33173001) (PMCID:PMC7667033)

Simwela, N., Hughes, K. R., Roberts, A. B., Rennie, M. T., Barrett, M. P. and Waters, A. P. (2020) Experimentally engineered mutations in a ubiquitin hydrolase, UBP-1, modulate in vivo susceptibility to artemisinin and chloroquine in Plasmodium berghei. Antimicrobial Agents and Chemotherapy, 64(7), (doi: 10.1128/AAC.02484-19) (PMID:32340987) (PMCID:PMC7318008)